Almost all cervical cancers are caused by an HPV infection which can be prevented through the HPV Vaccine among young girls. The HPV vaccine is safe and the most cost-effective tool against cervical cancer, protecting against at least 70 per cent of all cervical cancers. It is crucial to increase awareness and education, address cultural sensitivities, and ensure it is included in routine immunization programs to protect all girls from the risk of long-term HPV infection. HPV vaccination is the primary prevention of cervical cancer and is, therefore, an integral part of accelerating progress to cervical cancer elimination in Kenya.
How safe is the HPV vaccine?
The Center for Disease Control (CDC) has approved this vaccine as safe and effective. The vaccine was studied in thousands of people around the world, and these studies showed no serious safety concerns. One of the most common side effect reported is pain where the shot was given.According to the National Center for Biotechnology Information (NCBI), over 270 million doses of the HPV vaccine have been administered globally with no serious adverse event linked to the HPV vaccine and with an excellent
Goals:
- Increase awareness and advocacy for cervical cancer prevention and control through early detection and treatment.
- Increase HPV vaccination immunization coverage to 10-year-old girls in Kenya and reduce incidences of cervical cancer and decrease deaths from vaccine-preventable diseases.
- To create a diverse community of champions and other stakeholders who have the desire and training to participate in cervical prevention and control.
- Advocate for a sustained provision for the HPV Vaccine by the government and partners by 2022.
- To provide a holistic patient navigation to women found with advanced cervical cancer.
Read More about the HPV Vaccine in the following sites: